Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
Millions of Part D patients who rely on price-controlled drugs will see their out-of-pocket medication costs increase.
Medicare is big business, recently providing healthcare coverage to 68 million people. Before the 2024 election, fully 94% of ...
The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...
New bill introduced to stop 2.83% Medicare physician pay cut and provide 2% pay bump to stabilize practices and protect patient access to care.
The Inflation Reduction Act of 2022 has triggered a raft of changes to Medicare Part D plans and Medicare Advantage plans that affect prescription drug coverage in 2025. Here’s what to know.
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, ...
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...
Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback